News - Arena Pharmaceuticals

Filter

Current filters:

Arena Pharmaceuticals

Popular Filters

Arena and Eisai release data on obesity drug candidate lorcaserin to be used in CRL response

03-08-2011

USA-based Arena Pharmaceuticals (Nasdaq: ARNA) and Japanese partner Eisai (TYO: 4523) announced the completion…

Arena PharmaceuticalsEisailorcaserinMetabolicsPharmaceuticalResearch

Down but not out - obesity drugs continue journey towards approval

09-05-2011

Recent studies have shown that the chances of US Food and Drug Administration approval for early-stage…

Arena PharmaceuticalsContravelorcaserinMetabolicsOrexigen TherapeuticsPharmaceuticalRegulation

Back to top